In this video, Mazyar Shadman, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, highlights the importance of identifying molecular features of patients with chronic lymphocytic leukemia (CLL) to better understand how they may respond to therapeutic agents, and comments on the value of creating genomic databases containing this information. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.